Sanofi Healthcare India Private Limited, a active private limited company, was established on 10 March 1993 in Mumbai, Maharashtra, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24110MH1993PTC332584. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹90.65 Cr and a paid-up capital of ₹44.14 Cr.
Formerly known as Shantha Biotechnics Limited, Shantha Biotechnics Private Limited. It upholds a compliant status. Employing 1,076 professional, Its leadership includes Saravanan Devarajan (Whole-Time Director), Somak Ghosh (Additional Director), Mayur Dinesh Shah (Additional Director). Past directors included Alain Louis Marcel Merieux, Rajasekar Narayanasamy, Michel Dewilde. It holds no open charges and ₹161.65 Cr settled loans. Its latest AGM occurred on 25 October 2024, with the balance sheet filed on 31 March 2024. It is based at 2Nd Floor, Sanofi House, C.T.S-117B, L&T Business Park, Saki Vihar Road, Powa, I, Mumbai, Mumbai, Maharashtra, 400072.
U24110MH1993PTC332584
332584
10 March 1993
₹90.65 Cr
₹44.14 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sanofi Healthcare India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saravanan Devarajan | Whole-Time Director | 01 Apr 2022 | Current |
| Somak Ghosh | Additional Director | 13 Nov 2024 | Current |
| Mayur Dinesh Shah | Additional Director | 13 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Cfo(Kmp) | 13 Aug 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Director | 13 Jun 2011 | Past |
| Pramod Abcsdd | Director | 13 Jun 2011 | Past |
| Pramod Abcsdd | Managing Director | 30 Aug 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sanofi Healthcare India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.2% decrease. The company also saw a substantial fall in profitability, with a 1002.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 128.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sanofi Healthcare India had a promoter holding of 99.66% and a public holding of 0.33%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,616,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Nov 2008 | Idbi Bank Limited | ₹6.75 Cr | Satisfied |
| 27 Oct 2008 | Idbi Bank Limited | ₹17.00 Cr | Satisfied |
| 26 Mar 2008 | Export-Import Bank Of India | ₹30.00 Cr | Satisfied |
| 18 Aug 2005 | Technology Development Board( Department Of Science And Technology) | ₹15.00 Cr | Satisfied |
| 16 Aug 2005 | Export-Import Bank Of India | ₹6.25 Cr | Satisfied |
Explore comprehensive loan charge details -
Sanofi Healthcare India has a workforce of 1076 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sanofi Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanofi Healthcare India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Raviraj Jitendra Soni was appointed as a Company Secretary was appointed as a Company Secretary on 21 Nov 2024 & has been associated with this company since 1 year 3 days . was recorded as a recent event.
Progress on Somak Ghosh was appointed as a Additional Director was appointed as a Additional Director on 13 Nov 2024 & has been associated with this company since 1 year 11 days . was documented.
Mayur Dinesh Shah was appointed as a Additional Director was appointed as a Additional Director on 13 Nov 2024 & has been associated with this company since 1 year 11 days . was recorded as a recent event.
The activity Sanofi Healthcare India Private Limited last Annual general meeting of members was held on 25 Oct 2024 as per latest MCA records. was completed.
Sanofi Healthcare India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Saravanan Devarajan was appointed as a Whole-time director was appointed as a Whole-time director on 01 Apr 2022 & has been associated with this company since 3 years 7 months . was documented.
CORONA Remedies bought Myoril from Sanofi India for Rs234 crore. Sanofi sold it to focus on chronic diseases. Corona also bought other brands before. Myoril is worth Rs38 crore and growing at 6.8%. Sanofi also sold other brands to different companies. Indian pharma industry is growing at 10% and expected to reach Rs2,95,100 crore by 2026. E-pharmacy and new regulations will help it grow..
The CIN of Sanofi Healthcare India Private Limited is U24110MH1993PTC332584.
Sanofi Healthcare India Private Limited is headquartered at 2Nd Floor, Sanofi House, C.T.S-117B, L&T Business Park, Saki Vihar Road, Powa, I, Mumbai, Mumbai, Maharashtra, 400072.
Sanofi Healthcare India Private Limited was incorporated on 10 March 1993.
The current directors of Sanofi Healthcare India Private Limited are
The primary industry of Sanofi Healthcare India Private Limited is Manufacturing.
Sanofi Healthcare India Private Limited is unlisted.
The authorized capital of Sanofi Healthcare India Private Limited is ₹90.65 Cr, and the paid-up capital is ₹44.14 Cr.
The compliance status of Sanofi Healthcare India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX